A detailed history of E Fund Management Co., Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 13,217 shares of ABT stock, worth $1.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
13,217
Previous 12,487 5.85%
Holding current value
$1.5 Million
Previous $1.3 Million 16.11%
% of portfolio
0.08%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $73,051 - $86,234
730 Added 5.85%
13,217 $1.51 Million
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $142,331 - $158,877
1,413 Added 12.76%
12,487 $1.3 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $761,711 - $841,276
6,955 Added 168.85%
11,074 $1.26 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $48,071 - $58,843
533 Added 14.86%
4,119 $453,000
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $22,927 - $27,508
-240 Reduced 6.27%
3,586 $347,000
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $41,722 - $46,488
-414 Reduced 9.76%
3,826 $417,000
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $12,010 - $14,137
-124 Reduced 2.84%
4,240 $429,000
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $36,503 - $42,823
-384 Reduced 8.09%
4,364 $479,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $35,123 - $40,666
363 Added 8.28%
4,748 $459,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $816 - $986
-8 Reduced 0.18%
4,385 $476,000
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $49,370 - $60,204
-433 Reduced 8.97%
4,393 $520,000
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $7,856 - $9,619
-68 Reduced 1.39%
4,826 $679,000
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $110,477 - $122,219
947 Added 23.99%
4,894 $578,000
Q1 2021

May 12, 2021

BUY
$108.84 - $128.23 $429,591 - $506,123
3,947 New
3,947 $473,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.